Webb6 juni 2024 · Prostate-specific membrane antigen (PSMA) is a promising target for imaging diagnostics and targeted radionuclide therapy (theranostics) of prostate cancer and its metastases. Webb1 feb. 2024 · Prostate-specific membrane antigen (PSMA) is not an antigen (it is a transmembrane protein), is not specific to the prostate gland (it is expressed in other normal tissues), and is not specific to prostate cancer (it is expressed in many benign conditions and cancers other than prostate cancer).
PSMA Theranostics - YouTube
Webb[68Ga]Ga-PSMA-11 PET/CT plays a pivotal role in the diagnosis and staging of prostate cancer because of its higher sensitivity and detection rate compared with traditional choline PET/CT. A highly reproducible radiochemical yield of the radiopharmaceutical to be used in the clinical routine is an important parameter for planning and optimization of … Webb29 apr. 2024 · For PSMA theranostics, post-therapeutic dosimetry may be a useful tool to tailor the treatment protocol to a patient’s individual needs, e.g., by providing absorbed doses to organs at risk or the tumor. Nonetheless, such a whole-body tumor dosimetry applied to all relevant sites of disease is challenging [ 26 ]. biznet head office
PSMA Theranostics: Current Status and Future Directions
WebbProstate-specific membrane antigen (PSMA) is a credentialed imaging and therapy (theranostic) target for the detection and treatment of prostate cancer. PSMA-targeted … WebbLutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto) Request an Appointment for Prostate Cancer Care The information you provide on this secure form to request an … Webb25 juni 2024 · Marnix Lam noemt de Lutetium-177-PSMA behandeling een voorbeeld van theranostics, het combineren van diagnose en behandeling.Met een PSMA PET-scan … biznet high ping